- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
回落整理中且下跌趋势有所减缓。
- 长期趋势：
已有3家主力机构披露2025-12-31报告期持股数据，持仓量总计53.66万股，占流通A股0.34%
- 波段诊断：
-
技术面诊股
诊断结果：7.5技术面打败了83%的股票
技术面评分前10的股票
近期的平均成本为18.75元。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
平均成本
近期的平均成本为18.75元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"18.75","date":1773561576,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，接近行业平均水平。
[{"date":"2026.03.16","stock":"0.59","trade":null,"ind":"0.19"},{"date":"2026.03.13","stock":"0.21","trade":null,"ind":"-0.65"},{"date":"2026.03.12","stock":"0.38","trade":null,"ind":"-0.63"},{"date":"2026.03.11","stock":"-0.64","trade":null,"ind":"0.78"},{"date":"2026.03.10","stock":"1.85","trade":null,"ind":"2.04"},{"date":"2026.03.09","stock":"-0.59","trade":null,"ind":"-0.74"},{"date":"2026.03.06","stock":"2.21","trade":null,"ind":"0.59"},{"date":"2026.03.05","stock":"1.34","trade":null,"ind":"1.23"},{"date":"2026.03.04","stock":"-1.00","trade":null,"ind":"-0.75"},{"date":"2026.03.03","stock":"-1.69","trade":null,"ind":"-3.07"},{"date":"2026.03.02","stock":"-2.19","trade":null,"ind":"-0.20"},{"date":"2026.02.27","stock":"0.37","trade":null,"ind":"-0.06"},{"date":"2026.02.26","stock":"-1.32","trade":null,"ind":"0.19"},{"date":"2026.02.25","stock":"0.42","trade":null,"ind":"1.29"},{"date":"2026.02.24","stock":"0.80","trade":null,"ind":"1.36"},{"date":"2026.02.13","stock":"-0.27","trade":null,"ind":"-1.28"},{"date":"2026.02.12","stock":"-2.09","trade":null,"ind":"0.86"},{"date":"2026.02.11","stock":"-0.88","trade":null,"ind":"-0.35"},{"date":"2026.02.10","stock":"0.78","trade":null,"ind":"0.02"},{"date":"2026.02.09","stock":"0.52","trade":null,"ind":"2.17"},{"date":"2026.02.06","stock":"-0.99","trade":null,"ind":"-0.33"}]
明德生物,深证成指,医疗器械指数
压力支撑
该股压力位为18.73元，支撑位为18.61元。
[{"text":"\u538b\u529b\u4f4d","value":"18.73","date":1773590400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"18.61","date":1773590400,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.1资金面打败了48%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体无进出。
更新时间：03月17日 08:07
| 机构今日流向(万元) | -390.96 | 机构5日流向(万元) | -924.07 |
| 机构10日流向(万元) | -3691.17 | 机构20日流向(万元) | -9560.03 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少1302.87万股，其中基金数没有增加，主力净减仓41家，请投资者中长期谨慎为宜。
截止2025-12-31，共3家主力机构（基金3家），持仓量总计53.66万股，占流通A股0.34%
其中，基金持仓与2025-06-30相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：3家 ，持有53.66万股
从主力名单中消失：44家 ，原持有1356.53万股
其中，基金持仓与2025-06-30相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：3家 ，持有53.66万股
从主力名单中消失：44家 ，原持有1356.53万股
消息面诊股
诊断结果：3.3消息面打败了6%的股票
今日有利好新闻的公司
近期该股利空消息较多，投资时需谨慎。
更多>>个股资讯
- 明德生物：3月13日获融资买入242.72万元
2026-03-16 - 明德生物：3月12日获融资买入114.32万元
2026-03-13 - 明德生物：3月11日获融资买入233.50万元
2026-03-12 - 明德生物：3月10日获融资买入324.95万元
2026-03-11 - 明德生物：3月9日获融资买入393.79万元
2026-03-10 - 明德生物：3月6日获融资买入274.95万元
2026-03-09 - 地缘冲突持续，体外诊断板块中东出海影响几何？
2026-03-06 - 明德生物：3月5日获融资买入220.01万元
2026-03-06 - 明德生物：3月4日获融资买入242.97万元
2026-03-05 - 明德生物：3月3日获融资买入525.02万元
2026-03-04
消息列表
| 一般消息 | 募资投向 | 公司购买资产 | 2026-02-06 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2026-01-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-05 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-10-18 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-28 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 利好 | 分红转增 | 10派12元(含税) | 2025-04-25 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了1%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.03.16","price":"0.19","value":null},{"date":"2026.03.13","price":"-0.65","value":null},{"date":"2026.03.12","price":"-0.63","value":null},{"date":"2026.03.11","price":"0.78","value":null},{"date":"2026.03.10","price":"2.04","value":null},{"date":"2026.03.09","price":"-0.74","value":null},{"date":"2026.03.06","price":"0.59","value":null},{"date":"2026.03.05","price":"1.23","value":null},{"date":"2026.03.04","price":"-0.75","value":null},{"date":"2026.03.03","price":"-3.07","value":null},{"date":"2026.03.02","price":"-0.20","value":null},{"date":"2026.02.27","price":"-0.06","value":null},{"date":"2026.02.26","price":"0.19","value":null},{"date":"2026.02.25","price":"1.29","value":null},{"date":"2026.02.24","price":"1.36","value":null},{"date":"2026.02.13","price":"-1.28","value":null},{"date":"2026.02.12","price":"0.86","value":null},{"date":"2026.02.11","price":"-0.35","value":null},{"date":"2026.02.10","price":"0.02","value":null},{"date":"2026.02.09","price":"2.17","value":null},{"date":"2026.02.06","price":"-0.33","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 爱迪特 | 57.17% | 1.60% | 5.6分 |
| 2 | 英科医疗 | 40.96% | 19.93% | 5.4分 |
| 3 | 蓝帆医疗 | 30.82% | 17.09% | 5.4分 |
| 4 | 九安医疗 | 29.31% | 8.05% | 5.8分 |
| 5 | 振德医疗 | 25.77% | 6.16% | 6.1分 |
| 6 | 中源协和 | 19.92% | -1.07% | 5.5分 |
| 8 | 麦澜德 | 14.85% | 12.64% | 5.5分 |
| 10 | 心脉医疗 | 12.64% | 5.80% | 5.9分 |
| 12 | 可孚医疗 | 11.51% | 2.51% | 6.1分 |
| 14 | 康拓医疗 | 10.06% | 13.74% | 6.4分 |
| 16 | 天益医疗 | 9.57% | 8.41% | 5.4分 |
| 18 | 伟思医疗 | 7.29% | 0.12% | 5.4分 |
| 20 | 亚辉龙 | 6.37% | 8.55% | 4.7分 |
| 22 | 威高骨科 | 5.17% | 1.06% | 5.8分 |
| 24 | 三鑫医疗 | 4.85% | 2.26% | 5.4分 |
| 26 | 惠泰医疗 | 3.67% | 5.03% | 6.1分 |
| 28 | 翔宇医疗 | 3.32% | 5.82% | 4.9分 |
| 30 | 乐普医疗 | 3.25% | 7.10% | 6.1分 |
| 32 | 维力医疗 | 2.48% | 0.72% | 6.1分 |
| 34 | 华强科技 | 1.73% | -3.11% | 5.0分 |
| 36 | 海尔生物 | 1.67% | 4.64% | 5.2分 |
| 38 | 黄山胶囊 | 1.19% | 0.83% | 6.0分 |
| 40 | 浩欧博 | 0.96% | 2.28% | 5.6分 |
| 42 | 欧普康视 | 0.89% | 4.33% | 5.6分 |
| 44 | 新华医疗 | 0.65% | 2.04% | 5.0分 |
| 46 | ST凯利 | 0.00% | 1.81% | 5.1分 |
| 48 | 仁度生物 | -0.30% | 2.67% | 5.5分 |
| 50 | 力诺药包 | -0.77% | 8.05% | 5.7分 |
| 52 | 明德生物 | -1.31% | 2.39% | 4.7分 |
| 54 | 康德莱 | -1.50% | 0.77% | 5.6分 |
| 56 | - | -1.93% | 2.33% | 分 |
| 58 | 正川股份 | -2.17% | 0.50% | 5.2分 |
| 60 | 济高发展 | -2.33% | 0.60% | 4.7分 |
| 62 | 易瑞生物 | -2.44% | 1.81% | 5.6分 |
| 64 | 普门科技 | -2.69% | 2.37% | 5.4分 |
| 66 | 洁特生物 | -3.15% | 3.30% | 5.9分 |
| 68 | 奥泰生物 | -3.33% | 1.63% | 5.1分 |
| 70 | 科华生物 | -3.38% | 1.18% | 4.7分 |
| 72 | 睿昂基因 | -3.50% | 0.64% | 4.4分 |
| 74 | 迈克生物 | -4.07% | 0.96% | 4.3分 |
| 76 | 迪瑞医疗 | -4.10% | -1.64% | 4.2分 |
| 78 | 东方生物 | -4.12% | 1.61% | 5.2分 |
| 80 | 戴维医疗 | -4.46% | -1.72% | 5.9分 |
| 82 | 安图生物 | -4.55% | -0.34% | 5.1分 |
| 84 | 九强生物 | -4.61% | 0.48% | 4.0分 |
| 86 | 山东药玻 | -4.83% | -0.56% | 4.8分 |
| 88 | 麦克奥迪 | -5.05% | -2.50% | 4.9分 |
| 90 | 圣湘生物 | -5.21% | 2.82% | 5.6分 |
| 92 | 天臣医疗 | -5.62% | 0.70% | 6.1分 |
| 94 | 澳华内镜 | -5.85% | 2.39% | 4.4分 |
| 96 | 万东医疗 | -5.97% | -0.27% | 5.2分 |
| 98 | 透景生命 | -6.43% | -0.29% | 3.5分 |
| 100 | - | -6.58% | -2.11% | 分 |
| 102 | - | -6.64% | -3.98% | 分 |
| 104 | 五洲医疗 | -7.14% | 0.45% | 4.7分 |
| 106 | 楚天科技 | -7.35% | -0.78% | 4.6分 |
| 108 | 健帆生物 | -7.80% | 1.07% | 4.4分 |
| 110 | 三诺生物 | -7.95% | -0.89% | 5.2分 |
| 112 | 热景生物 | -8.03% | -5.56% | 3.8分 |
| 114 | 美好医疗 | -8.07% | -3.09% | 4.9分 |
| 116 | 爱博医疗 | -8.20% | -0.22% | 5.0分 |
| 118 | 南微医学 | -8.85% | -2.79% | 5.2分 |
| 120 | 大博医疗 | -9.23% | 1.83% | 4.7分 |
| 122 | - | -9.34% | -3.68% | 分 |
| 124 | 硕世生物 | -9.57% | 8.15% | 4.2分 |
| 126 | 天智航 | -11.28% | 1.27% | 4.5分 |
| 128 | 康为世纪 | -12.28% | -1.09% | 4.3分 |
| 130 | 瑞迈特 | -13.83% | -1.58% | 4.9分 |
| 132 | 北芯生命 | -15.69% | 3.35% | 4.9分 |
| 134 | 国发股份 | -18.21% | -4.44% | 4.2分 |
| 136 | 海泰新光 | -18.87% | 0.25% | 5.4分 |
| 138 | - | - | -6.35% | 分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 98/243 ， 106/243。
[{"date":"2025-09-30","value":"0.24","vol":"2.98"},{"date":"2025-06-30","value":"0.22","vol":"2.34"},{"date":"2025-03-31","value":"-0.06","vol":"1.16"},{"date":"2024-12-31","value":"1.26","vol":"0.56"},{"date":"2024-09-30","value":"1.36","vol":"4.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.24 | 0.22 | -0.06 | 1.26 | 1.36 |
| 行业(%) | 2.98 | 2.34 | 1.16 | 0.56 | 4.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"32.31","vol":"51.74"},{"date":"2025-06-30","value":"40.82","vol":"52.05"},{"date":"2025-03-31","value":"16.37","vol":"51.42"},{"date":"2024-12-31","value":"53.89","vol":"52.52"},{"date":"2024-09-30","value":"51.79","vol":"53.36"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
32.31 | 40.82 | 16.37 | 53.89 | 51.79 |
| 行业(%) | 51.74 | 52.05 | 51.42 | 52.52 | 53.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 65/243 ， 107/243。
[{"date":"2025-09-30","value":"0.53","vol":"0.26"},{"date":"2025-06-30","value":"-9.71","vol":"-1.09"},{"date":"2025-03-31","value":"14.76","vol":"-0.12"},{"date":"2024-12-31","value":"-53.30","vol":"1.15"},{"date":"2024-09-30","value":"-63.95","vol":"0.77"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
0.53 | -9.71 | 14.76 | -53.30 | -63.95 |
| 行业(%) | 0.26 | -1.09 | -0.12 | 1.15 | 0.77 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-83.30","vol":"-15.37"},{"date":"2025-06-30","value":"-80.82","vol":"-18.14"},{"date":"2025-03-31","value":"-111.43","vol":"-2.59"},{"date":"2024-12-31","value":"-0.54","vol":"-23.09"},{"date":"2024-09-30","value":"-44.30","vol":"-19.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-83.30 | -80.82 | -111.43 | -0.54 | -44.30 |
| 行业(%) | -15.37 | -18.14 | -2.59 | -23.09 | -19.92 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 127/243 ， 52/243。
[{"date":"2025-09-30","value":"0.04","vol":"0.25"},{"date":"2025-06-30","value":"0.02","vol":"0.17"},{"date":"2025-03-31","value":"0.01","vol":"0.08"},{"date":"2024-12-31","value":"0.05","vol":"0.36"},{"date":"2024-09-30","value":"0.03","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.04 | 0.02 | 0.01 | 0.05 | 0.03 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.36 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.67","vol":"1.66"},{"date":"2025-06-30","value":"1.00","vol":"1.12"},{"date":"2025-03-31","value":"0.74","vol":"0.55"},{"date":"2024-12-31","value":"1.53","vol":"2.32"},{"date":"2024-09-30","value":"0.87","vol":"1.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.67 | 1.00 | 0.74 | 1.53 | 0.87 |
| 行业(次) | 1.66 | 1.12 | 0.55 | 2.32 | 1.64 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"-0.85","vol":"14.74"},{"date":"2025-06-30","value":"-82.41","vol":"15.17"},{"date":"2025-03-31","value":"-43.63","vol":"4.22"},{"date":"2024-12-31","value":"30.71","vol":"29.38"},{"date":"2024-09-30","value":"48.62","vol":"15.46"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -0.85 | -82.41 | -43.63 | 30.71 | 48.62 |
| 行业 | 14.74 | 15.17 | 4.22 | 29.38 | 15.46 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"1.64","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.38","vol":"2.17"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.64 | - | 2.38 | - |
| 行业 | 0.01 | 1.57 | 0.00 | 2.17 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 124/243 ， 78/243。
[{"date":"2025-09-30","value":"15.95","vol":"5.66"},{"date":"2025-06-30","value":"14.48","vol":"5.47"},{"date":"2025-03-31","value":"10.22","vol":"5.84"},{"date":"2024-12-31","value":"4.84","vol":"5.30"},{"date":"2024-09-30","value":"3.29","vol":"5.83"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
15.95 | 14.48 | 10.22 | 4.84 | 3.29 |
| 行业 | 5.66 | 5.47 | 5.84 | 5.30 | 5.83 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"4.23","vol":"4.51"},{"date":"2025-06-30","value":"3.43","vol":"4.35"},{"date":"2025-03-31","value":"2.71","vol":"4.73"},{"date":"2024-12-31","value":"2.69","vol":"4.27"},{"date":"2024-09-30","value":"2.28","vol":"4.70"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
4.23 | 3.43 | 2.71 | 2.69 | 2.28 |
| 行业 | 4.51 | 4.35 | 4.73 | 4.27 | 4.70 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 122/243 ， 121/243。
[{"date":"2025-09-30","value":"6.13","vol":"22.07"},{"date":"2025-06-30","value":"6.62","vol":"22.01"},{"date":"2025-03-31","value":"7.69","vol":"21.19"},{"date":"2024-12-31","value":"8.71","vol":"21.94"},{"date":"2024-09-30","value":"10.54","vol":"20.60"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
6.13 | 6.62 | 7.69 | 8.71 | 10.54 |
| 行业(%) | 22.07 | 22.01 | 21.19 | 21.94 | 20.60 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.07","vol":"0.71"},{"date":"2025-06-30","value":"0.07","vol":"0.58"},{"date":"2025-03-31","value":"0.09","vol":"0.56"},{"date":"2024-12-31","value":"0.10","vol":"0.55"},{"date":"2024-09-30","value":"0.12","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.07 | 0.07 | 0.09 | 0.10 | 0.12 |
| 行业(%) | 0.71 | 0.58 | 0.56 | 0.55 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"14.13","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"42.08","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.75","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.75","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]